miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway

Tumor Biology

Volumn 36, Issue 7, 2015, Pages 5323-5331

  Yan, Zhiyong ^a   Che, Shusheng ^a   Wang, Jianpeng ^a   Jiao, Yingbing ^a   Wang, Chao ^a   Meng, Qinghai ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Glioma; HBP1; miR 155; Wnt

Indexed keywords

BETA CATENIN; HERMES ANTIGEN; HMG BOX TRANSCRIPTION FACTOR 1; KI 67 ANTIGEN; MICRORNA 155; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; MESSENGER RNA; MICRORNA; MIRN155 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXIN2 GENE; CD44 GENE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LGR5 GENE; MALE; MICRORNA RECOGNITION ELEMENT; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA STRUCTURE; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; APOPTOSIS; BIOSYNTHESIS; BRAIN TUMOR; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; APOPTOSIS; BETA CATENIN; BRAIN NEOPLASMS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; MICE; MICRORNAS; RNA, MESSENGER; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84938207617     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3193-9     Document Type: Article

References (20)

1. Goodenberger ML, Jenkins RB. Genetics of adult glioma. Cancer Genet. 2012;205(12):613–21.
2. Wang Y, Jiang T. Understanding high grade glioma: molecular mechanism, therapy and comprehensive management. Cancer Lett. 2013;331(2):139–46. doi:10.1016/j.canlet.2012.12.024.
3. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122(1):6–7. doi:10.1016/j.cell.2005.06.036.
4. Chen Z, Ma T, Huang C, Hu T, Li J. The pivotal role of microRNA-155 in the control of cancer. J Cell Physiol. 2014;229(5):545–50. doi:10.1002/jcp.24492.
5. Poltronieri P, D’Urso PI, Mezzolla V, D’Urso OF. Potential of anti-cancer therapy based on anti-miR-155 oligonucleotides in glioma and brain tumours. Chem Biol Drug Des. 2013;81(1):79–84. doi:10.1111/cbdd.12002.
6. Zhang K, Zhang J, Han L, Pu P, Kang C. Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol: Off J Soc NeuroImmune Pharmacol. 2012;7(4):740–9. doi:10.1007/s11481-012-9359-y.
7. Yan Z, Wang J, Wang C, Jiao Y, Qi W, Che S. miR-96/HBP1/Wnt/beta-catenin regulatory circuitry promotes glioma growth. FEBS Lett. 2014;588(17):3038–46. doi:10.1016/j.febslet.2014.06.017.
8. Ma L, Liu J, Shen J, Liu L, Wu J, Li W, et al. Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells. Cancer Biol Ther. 2010;9(7):554–61.
9. Liu J, Ma L, Li C, Zhang Z, Yang G, Zhang W. Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells. Mol Oncol. 2013;7(6):1043–55. doi:10.1016/j.molonc.2013.08.003.
10. Ma L, Liu J, Liu L, Duan G, Wang Q, Xu Y, et al. Overexpression of the transcription factor MEF2D in hepatocellular cancer sustains malignant character by suppressing G2/M transition genes. Cancer Res. 2014. doi:10.1158/0008-5472.CAN-13-2171.
11. Wang B, Liu J, Ma LN, Xiao HL, Wang YZ, Li Y, et al. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44(+) gastric cancer cells via attenuating Wnt signaling. J Gastroenterol. 2013;48(7):798–808. doi:10.1007/s00535-012-0711-z.
12. Liu S, Yin F, Zhang J, Wicha MS, Chang AE, Fan W, et al. Regulatory roles of miRNA in the human neural stem cell transformation to glioma stem cells. J Cell Biochem. 2014;115(8):1368–80. doi:10.1002/jcb.24786.
13. D’Urso PI, D’Urso OF, Storelli C, Mallardo M, Gianfreda CD, Montinaro A, et al. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. International journal of oncology. 2012;41(1):228–34. doi:10.3892/ijo.2012.1420.
14. Ling N, Gu J, Lei Z, Li M, Zhao J, Zhang HT, et al. microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol Rep. 2013;30(5):2111–8. doi:10.3892/or.2013.2685.
15. Zhou J, Wang W, Gao Z, Peng X, Chen X, Chen W, et al. MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PLoS One. 2013;8(12):e83055. doi:10.1371/journal.pone.0083055.
16. Meng W, Jiang L, Lu L, Hu H, Yu H, Ding D, et al. Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis. Cell Biol Int. 2012;36(7):653–9. doi:10.1042/CBI20100918.
17. Lages E, Guttin A, El Atifi M, Ramus C, Ipas H, Dupre I, et al. MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. PLoS One. 2011;6(5):e20600. doi:10.1371/journal.pone.0020600.
18. Qiu S, Lin S, Hu D, Feng Y, Tan Y, Peng Y. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. J Transl Med. 2013;11:10. doi:10.1186/1479-5876-11-10.
19. Sun J, Shi H, Lai N, Liao K, Zhang S, Lu X. Overexpression of microRNA-155 predicts poor prognosis in glioma patients. Med Oncol. 2014;31(4):911. doi:10.1007/s12032-014-0911-x.
20. Xia Z, Wei P, Zhang H, Ding Z, Yang L, Huang Z, et al. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of beta-catenin/Wnt signaling. Mol Cancer Res: MCR. 2013;11(9):1101–11. doi:10.1158/1541-7786.MCR-13-0044.